Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-04-03
2009-11-17
Fetterolf, Brandon J (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07618789
ABSTRACT:
Method of diagnosing cancer in a male mammal comprising obtaining and assaying a test sample for an increased level of semenogelin; method of diagnosing cancer in a female mammal comprising obtaining and assaying a test sample for the presence of semenogelin; methods of prognosticating and assessing the effectiveness of treatment of a cancer in a mammal comprising measuring the level of semenogelin in a test sample; method of inducing an immune response to a cancer in a mammal comprising administering to the mammal a composition comprising (a) an immune-response inducing effective amount of (i) semenogelin or (ii) antibody thereto or (b) a recombinant vector encoding and expressing an immune-response inducing effective amount of (i) or (ii); and composition comprising a carrier and (a) an immune-response inducing effective amount of (i) a polypeptide of any of SEQ ID NOS:1-27 or (ii) antibody thereto or (b) a recombinant vector encoding and expressing an immune-response inducing effective amount of (i) or (ii).
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4569788 (1986-02-01), Mulshine et al.
patent: 5279721 (1994-01-01), Schmid
patent: 5599686 (1997-02-01), DeFeo-Jones et al.
patent: 5866679 (1999-02-01), DeFeo-Jones et al.
patent: 5972615 (1999-10-01), An et al.
patent: 6040138 (2000-03-01), Lockhart et al.
patent: 6130204 (2000-10-01), DeFeo-Jones et al.
patent: 6143864 (2000-11-01), DeFeo-Jones et al.
patent: 6171796 (2001-01-01), An et al.
patent: 6177404 (2001-01-01), DeFeo-Jones et al.
patent: 6197506 (2001-03-01), Fodor et al.
patent: 6265540 (2001-07-01), Isaacs et al.
patent: 6335170 (2002-01-01), Orntoft
patent: 2001/0007748 (2001-07-01), An et al.
patent: WO 98/52966 (1998-11-01), None
patent: WO 99/04265 (1999-01-01), None
patent: WO 99/61471 (1999-12-01), None
patent: WO 01/93861 (2001-12-01), None
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25).
Embleton et al (Immunol Ser, 1984, 23:181-207).
Hsu (in Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p. 764).
Weiner (Seminars Oncology, vol. 26, No. 4, 1999, pp. 41-50).
Kaiser (Science, 2006, 3.13:1370).
Internal Medicine, 4th Edition, Editor-in-chief Jay Stein, Elsevier Science, 1998 Chapters 71-72, pp. 699-715.
Lilja et al (PNAS, 1992, 89:4559-4563.
Rodrigues et al. (Clinical Cancer Research 2001; vol. 7: 854-860).
Lundwall et al .(Molecular Human Reproduction 2002: vol. 8: 805-811).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12:320).
Bjartell et al., “Distribution and Tissue Expression of Semenogelin I and II in Man as Demonstrated by In Situ Hybridization and Immunocytochemistry,”J. Androl., 17(1), 17-26 (1996).
Krutzsch et al., “Identification of an α3β1Integrin Recognition Sequence in Thrombospondin-1,”J. Biol. Chem., 274(34), 24080-24086 (1999).
Malm et al., “Isolation and Characterization of the Major Gel Proteins in Human Semen, Semenogelin I and Semenogelin II,”Eur. J. Biochem., 238, 48-53 (1996).
Rodrigues et al., “Semenogelins Are Ectopically Expressed in Small Cell Lung Carcinoma,”Clin. Can. Res., 7, 854-860 (2001).
Walker et al., “Isothermal in vitro Amplification of DNA by a Restriction Enzyme/DNA Polymerase System,”Proc. Natl. Acad. Sci. USA, 89, 392-396 (1992).
Lundwall et al., “Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues,”Mol. Hum. Reprod., 8 (9), 805-810 (2002).
Krutzsch Henry C.
Krutzsch, legal representative Christine
Roberts David D.
Fetterolf Brandon J
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Secretary of
LandOfFree
Use of semenogelin in the diagnosis, prognosis and treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of semenogelin in the diagnosis, prognosis and treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of semenogelin in the diagnosis, prognosis and treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061823